Business Standard

Covid-19: Global vaccine program COVAX low on funds, seeks $5.2 billion

The UN-backed programme known as COVAX has delivered just over 1 billion doses since shipments started nearly a year ago

Covaxin has started trials on children; it would be for children who are two years or older

Representational image

AP Geneva
The global initiative to share coronavirus vaccines equally between rich and poor countries asked Wednesday for USD 5.2 billion in funds to be able to keep buying doses in coming months.
The UN-backed programme known as COVAX has delivered just over 1 billion doses since shipments started nearly a year ago.
The initial goal was to deliver 2 billion doses by the end of 2021, but COVAX's lack of cash when vaccine deals were being made gave it a late start, and most of the world's vaccine doses have gone to wealthy nations who locked in contracts.
As things stand now, less than 10 per cent of the people in low-income countries have received at least one dose, while more than 60 per cent of world's overall population has been vaccinated some with three or four doses.
Seth Berkley, the CEO of GAVI, the global health organization that co-founded the COVAX initiative, said it was key to supplying poor countries with vaccine shots now and in the future but we right now are basically out of money.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 20 2022 | 1:37 AM IST

Explore News